Home
Name
NAC
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for NAC
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Chlorethazine Hydrochloride
Chlormethine Hydrochloride
Dichloromethyl-diethylamine-HCl
Mechlorethamine Hydrochloride
Meclorethamine
Mustargen
Mustargen-HCl
Mustine
Nitrogen Mustard
WR-147650
Valchlor
Abbreviations
HN2
NH2
NH2-HCl
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
000762
762
Primary Site
Histology
None
Remarks
FDA approved uses on bronchogenic carcinoma, chronic lymphocytic leukemia, Hodgkin's lymphoma, Non-Hodgkin lymphoma, lymphosarcoma, and malignant effusion.
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
